Human naive CD4 T-Cell clones specific for HIV envelope persist for years in vivo in the absence of antigenic challenge

Journal of Acquired Immune Deficiency Syndromes

Volumn 40, Issue 2, 2005, Pages 132-139

  Li Pira, Giuseppina ^a   Bottone, Laura ^b   Ivaldi, Federico ^a   Del Galdo, Francesco ^c   Papa, Francesca ^c   Accolla, Roberto ^b   Koopman, Gerrit ^d   Abbate, Gianfranco ^c   De Berardinis, Piergiuseppe ^e   D'Apice, Luciana ^e   De Palma, Raffaele ^c   Manca, Fabrizio ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^e INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

Author keywords

CD4 cells; HIV gp120; Immunodominant epitope; T lymphocytes; T cell receptors; T cell repertoire

Indexed keywords

CD4 ANTIGEN; EPITOPE; GAMMA INTERFERON; GLYCOPROTEIN GP 120; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOSTIMULATION; MULTIGENE FAMILY; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; THYMUS;

AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CLONE CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP120; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 25844507067     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000177842.67392.e2     Document Type: Article

References (49)

1. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science. 1997;278:1447-1450.
2. Altfeld M, Rosenberg ES. The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1. Curr Opin Immunol. 2000;12: 375-380.
3. Freitas AA, Rocha B, Coutinho AA. Lymphocyte population kinetics in the mouse. Immunol Rev. 1986;91:5-37.
4. Tanchot C, Lemonnier FA, Perarnau B, et al. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science. 1997; 276:2057-2062.
5. Miller JF. Effect of thymectomy in adult mice on immunological responsiveness. Nature. 1965;208:1337-1338.
6. Tanchot C, Rocha B. The peripheral T cell repertoire: independent homeostatic regulation of virgin and activated CD8+ T cell pools. Eur J Immunol. 1995;25:2127-2136.
7. Sprent J, Schaefer M, Hurd M, et al. Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype. J Exp Med. 1991;174:717-728.
8. Bell EB, Sparshott SM, Drayson MT, et al. The stable and permanent expansion of functional T lymphocytes in athymic nude rats after a single injection of mature T cells. J Immunol. 1987;139:1379-1384.
9. Viret C, Wong FS, Janeway CA Jr. Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition. Immunity. 1999;10;559-568.
10. Freitas AA, Rocha B. Population biology of lymphocytes: the flight for survival. Annu Rev Immunol. 2000;18:83-111.
11. Sprent J, Tough DF. Lymphocyte life-span and memory. Science. 1994; 265:1395-1400.
12. Norman A, Sasaki MS, Ottoman RE, et al. Lymphocyte lifetime in women. Science. 1965;147:745.
13. Nowell PC. Unstable chromosome changes in tuberculin-stimulated leukocyte cultures from irradiated patients. Evidence for immunologically committed, long-lived lymphocytes in human blood. Blood. 1965;26: 798-804.
14. Buckton KE, Brown WM, Smith PG. Lymphocyte survival in men treated with x-rays for ankylosing spondylitis. Nature. 1967;214:470-473.
15. Michie CA, McLean A, Alcock C, et al. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature. 1992;360:264-265.
16. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. 2002;2:251-262.
17. Kern F, Li Pira G, Gratama JW, et al. Measuring antigen specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer. Trends Immunol. (In press).
18. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature. 1988;334:395-402.
19. Hou S, Hyland L, Ryan KW, et al. Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature. 1994;369:652-654.
20. Whitmire JK, Asano MS, Murali-Krishna K, et al. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection. J Virol. 1998;72:8281-8288.
21. Manca F, Habeshaw J, Dalgleish A. The naive repertoire of human T helper cells specific for gp120, the envelope glycoprotein of HIV. J Immunol. 1991;146:1964-1971.
22. Manca F. Galactose receptors and presentation of HIV envelope glycoprotein to specific human T cells. J Immunol. 1992;148:2278-2282.
23. Manca F, Li Pira G, Fenoglio D, et al. Recognition of human T-leukemia virus (HTLV-1) envelope by human CD4+ T-cell lines from HTLV-1 seronegative individuals: specificity and clonal heterogeneity. Blood. 1995;85:1547-1554.
24. Manca F, Fenoglio D, Valle MT, et al. Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope-specific antibodies. Eur J Immunol. 1995;25:1217-1223.
25. Manca F, Habeshaw JA, Dalgleish AG, et al. Role of flanking variable sequences in antigenicity of consensus regions of HIV gp120 for recognition by specific human T helper clones. Eur J Immunol. 1993;23:269-274.
26. Manca F, De Berardinis P, Fenoglio D, et al. Antigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: effect on T helper cell repertoire selection. Eur J Immunol. 1996;26:2461-2469.
27. Caivano A, D'Apice L, Tiberio C, et al. Design of cassette vectors permitting cloning of all types of human TCR variable alpha and beta regions. J Immunol Methods. 2001;8875:124-134.
28. Wills MR, Carmichael AJ, Mynard K, et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol. 1996;70:7569-7579.
29. Li Pira G, Bottone L, Ivaldi F, et al. Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution. Int Immunol 2004;16:635-642.
30. Li Pira G, Bottone L, Ivaldi F, et al. Generation of cytomegalovirus specific CD4 T cell lines devoid of alloreactivity using a cocktail of CMV-pp65 peptides for reconstitution of the Th repertoire. J Infect Dis. 2005;191:215-226.
31. Oksenberg JR. The Antigen T Cell Receptor: Selected Protocols and Applications. New York: Chapman and Hall; 1997.
32. De Palma R, Gorski J. Restricted and conserved T-cell repertoires involved in allorecognition of class II major histocompatibility complex. Proc Natl Acad Sci USA. 1995;92:8836-8840.
33. Lim A, Baron V, Ferradini L, et al. Combination of MHC-peptide multimer-based T cell sorting with the immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses. J Immunol Methods. 2002;261:177-194.
34. De Palma R, Mango I, Del Galdo F, et al. Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes. Cancer Res. 2004;64:8068-8076.
35. Moss PA, Rosenberg WM, Bell JI. The human T cell receptor in health and disease. Annu Rev Immunol. 1992;10:71-96.
36. Ashwell JD, Chen C, Schwartz RH. High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules. J Immunol. 1986;136:389-395.
37. Selin LK, Nahill SR, Welsh RM. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J Exp Med. 1994;179: 1933-1943.
38. Di Rosa F, Ramaswamy S, Ridge JP, et al. On the lifespan of virgin T lymphocytes. J Immunol. 1999;163:1253-1257.
39. Hemmer B, Gran B, Zhao Y, et al. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med. 1999; 5:1375-1382.
40. Vyakarnam A, Matear PM, Cranenburg C, et al. T cell responses to peptides covering the gag p24 region of HIV-1 occur in HIV-1 seronegative individuals. Int Immunol. 1991;3:939-947.
41. Venturini S, Mosier DE, Burton DR, et al. Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization. J Virol. 2002;76:6987-6999.
42. Tan JT, Dudl E, LeRoy E, et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA. 2001; 98:8732-8737.
43. Schluns KS, Kieper WC, Jameson SC, et al. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol. 2000;1:426-432.
44. Dai Z, Lakkis FG. Cutting edge: secondary lymphoid organs are essential for maintaining the CD4, but not CD8, naive T cell pool. J Immunol. 2001;167:6711-6715.
45. Kronenberg M, Siu G, Hood LE, et al. The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Annu Rev Immunol. 1986; 4:529-591.
46. Davis MM. T cell receptor gene diversity and selection. Annu Rev Biochem. 1990;59:475-496.
47. Brodie SJ, Lewinsohn DA, Patterson BK, et al. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat Med. 1999;5: 34-41.
48. Macallan DC, Wallace D, Zhang Y, et al. Rapid turnover of effector-memory CD4(+) T cells in healthy humans. J Exp Med. 2004;200:255-260.
49. Norris PJ, Moffett HF, Yang OO, et al. Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells. J Virol. 2004;78:8844-8851.